| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.7M | -23.1% | -56.3% |
| Cost of Revenue | $2.0M | -14.4% | -49.1% |
| Gross Profit | -$288K | -161.5% | -1977.0% |
| R&D Expense | $39K | -4.2% | +3.6% |
| SG&A Expense | $1.4M | -37.3% | -48.7% |
| Operating Income | -$2.0M | +17.9% | +29.3% |
| Pre-tax Income | -$2.0M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $3.5M | -58.0% | +1014.3% |
| Accounts Receivable | $195K | +73.9% | +16.2% |
| Current Assets | $6.9M | -20.6% | +479.4% |
| Total Assets | $12.9M | -10.9% | +284.0% |
| Current Liabilities | $3.6M | +22.7% | -45.9% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$8.9M | — | — |
| Investing Cash Flow | -$2.2M | — | — |
| Financing Cash Flow | $8.7M | — | — |
| +17.6% |
| +31.8% |
| Net Income | -$2.0M | +17.6% | +31.8% |
| EPS (Basic) | -$0.59 | +35.9% | +98.7% |
| EPS (Diluted) | -$0.59 | +35.9% | +98.7% |
| $3.7M |
| +16.7% |
| -56.3% |
| Stockholders' Equity | $9.2M | -18.5% | +283.5% |